Geron issued UK Dolly patents

Article Abstract:

Menlo Park, CA-based Geron Corp. reported the issuance of two patents by the UK Patent Office for the nuclear transfer technology used to produce Dolly the sheep. Dolly was the first animal cloned from an adult cell. Geron obtained the license rights to the technology with the acquisition of Roslin Bio-Med Ltd.

Asset sales & divestitures, Acquisitions & mergers, Foreign operations, Research & Development, Scientific Research and Development Services, Research institutes, Roslin Bio-Med Ltd.

---

Geron issued UK Dolly patents

Article Abstract:

Geron Corp. was granted two patents by the UK Patent Office for its nuclear transfer technology. The technology is used to produced Dolly the sheep, the first cloned animal from an adult cell.

Genetic Engineering

---

Competition between flu drugs feverishly anticipated. (Gilead Sciences, Hoffmann La Roche and Glaxo Wellcome introduce new drugs)

Article Abstract:

Three leading biopharmaceutical companies, Gilead Sciences Inc., Hoffmann La-Roche Inc., and Glaxo Wellcome PLC have introduced antiviral drugs to help fight the flu this year.

Market information - general, Product introduction, Pharmaceutical Preparation Manufacturing, Viral Disease R&D, Antiinfective Preparations NEC, Antiviral Respiratory Preps, Anti-infective agents, Glaxo Wellcome PLC, Viral research, Antiviral agents, Gilead Sciences Inc., Respiratory system agents, Hoffmann-La Roche Inc.

Similar abstracts:

• Abstracts: Information technology as competitive advantage: the role of human, business, and technology resources. Competitive advantage: logical and philosophical considerations
• Abstracts: Destination services of Colorado Inc. Commercial Financial Services, Inc. Medline
• Abstracts: Firms' knowledge-sharing strategies in the global innovation system: empirical evidence from the flat panel display industry
• Abstracts: PR pros find middle way in noisy globalization debate. Celebs stand tall in wake of terror attacks. Video pros split on power of Internet
• Abstracts: Don't miss the action when a big one comes along. In the public eye. End of days

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.